---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000751"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-07-21T23:59:59+00:00"
generated_at: "2026-06-13T04:55:05.878688+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# BioSig AI Sciences raises $495k via private placement; BioSig retains 84.5% ownership

## Summary
- BioSig subsidiary BioSig AI Sciences issued 495,000 shares at $1.00 each to institutional/accredited investors.
- BioSig Technologies retains approximately 84.5% ownership of BioSig AI after the closing.
- Laidlaw & Company (UK) Ltd. received a warrant for 40,500 shares at $1.00 per share, expiring in 5 years.
- Shares and warrant are unregistered, sold under Section 4(a)(2) and Regulation D.

## SEC filing metadata
- accession: 0001185185-23-000751
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-07-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000751/0001185185-23-000751-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000751/biosig20230719_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000751
- JSON: https://secwatch.observer/filing/0001185185-23-000751.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000751.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $495,000 (effective 2023-07-19).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional and accredited investors
  - Value: $495,000
  - Effective: 2023-07-19
  source text: On July 19, 2023, BioSig AI Sciences, Inc., f/k/a NeuroClear Technologies Inc. (“BioSig AI”), a subsidiary of BioSig Technologies, Inc. (“BioSig”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which BioSig AI agreed to sell an aggregate of 495,000 shares (the “Shares”) of BioSig AI’s common stock, par value $0.001 per share (the “Common Stock”) for an aggregate purchase price of $495,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000751/0001185185-23-000751-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.